[144] Atkore Inc. SEC Filing
Rhea-AI Filing Summary
Atkore Inc. (ATKR) has a planned sale of 1,000 shares of its common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $65,010 based on the price used in the notice. The filing notes that there were 33,655,743 shares of this class outstanding, providing context for the size of the transaction. These 1,000 shares were originally acquired on 11/01/2019 as performance stock units from the issuer, with the same date listed as the payment date and the nature of payment described as N/A. The person for whose account the securities are to be sold represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for ATKR disclose?
The Form 144 for Atkore Inc. (ATKR) discloses a planned sale of 1,000 shares of common stock under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on the NYSE.
How many ATKR shares are planned to be sold and what is their market value?
The notice states that 1,000 common shares are to be sold with an aggregate market value of $65,010 based on the price used in the filing.
When were the ATKR shares being sold under Form 144 originally acquired?
The 1,000 shares were acquired on 11/01/2019 as performance stock units from the issuer, with the same date listed as the payment date.
How many Atkore (ATKR) common shares were outstanding according to the Form 144 notice?
The notice reports that there were 33,655,743 shares of the relevant class of common stock outstanding, as a baseline for the transaction size.
On which exchange will the ATKR shares in this Form 144 notice be sold?
The planned sale of the 1,000 ATKR common shares is identified as occurring on the NYSE.
What representation does the selling person make in the ATKR Form 144 filing?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.